Noora Sjösten1, Jussi Vahtera2, Paula Salo2, Tuula Oksanen2, Tarja Saaresranta3, Marianna Virtanen4, Jaana Pentti2, Mika Kivimäki5. 1. Finnish Institute of Occupational Health, Turku Finland, Finland. Electronic address: noora.sjosten@ttl.fi. 2. Finnish Institute of Occupational Health, Turku Finland, Finland. 3. Department of Pulmonary Diseases and Sleep Research Unit, Department of Physiology, University of Turku, Turku, Finland. 4. Finnish Institute of Occupational Health, Helsinki, Finland. 5. Department of Epidemiology and Public Health, University College London, London, UK.
Abstract
BACKGROUND: The impact of sleep apnea on work disability, in terms of sickness absence and disability pension, is unclear. We sought to estimate the total number of lost workdays caused by sleep apnea either due to medically certified sickness absences or disability pensions during the 5 years prior to the year of a sleep apnea diagnosis. METHODS: This is a register-linkage case-control study of Finnish public sector employees who had received a diagnosis of sleep apnea between 1995 and 2005 (n = 957) and randomly selected control subjects who had not received a diagnosis of sleep apnea (n = 4,785), matched for age, gender, socioeconomic position, type of employment, and organization. The annual sum of lost workdays, due to either medically certified sickness absences or disability pensions prior to diagnosis, was calculated for each participant (mean follow-up time, 5 years). RESULTS: After adjustment for comorbid conditions (eg, hypertension, ischemic heart disease, diabetes, asthma/other chronic lung disease, and depression), an increased risk of lost workdays was found in employees in whom sleep apnea developed compared to control subjects (rate ratio [RR], 1.61; 95% confidence interval [CI], 1.24 to 2.09 in men; and RR, 1.80; 95% CI, 1.43 to 2.28 in women). In women, the excess risk was already pronounced 5 years prior to the year of diagnosis, whereas in men the highest risk was noticed 1 year before the year of diagnosis. CONCLUSION: Sleep apnea may severely threaten work ability years before diagnosis. These results emphasize the importance of the early identification and treatment of employees with sleep apnea.
BACKGROUND: The impact of sleep apnea on work disability, in terms of sickness absence and disability pension, is unclear. We sought to estimate the total number of lost workdays caused by sleep apnea either due to medically certified sickness absences or disability pensions during the 5 years prior to the year of a sleep apnea diagnosis. METHODS: This is a register-linkage case-control study of Finnish public sector employees who had received a diagnosis of sleep apnea between 1995 and 2005 (n = 957) and randomly selected control subjects who had not received a diagnosis of sleep apnea (n = 4,785), matched for age, gender, socioeconomic position, type of employment, and organization. The annual sum of lost workdays, due to either medically certified sickness absences or disability pensions prior to diagnosis, was calculated for each participant (mean follow-up time, 5 years). RESULTS: After adjustment for comorbid conditions (eg, hypertension, ischemic heart disease, diabetes, asthma/other chronic lung disease, and depression), an increased risk of lost workdays was found in employees in whom sleep apnea developed compared to control subjects (rate ratio [RR], 1.61; 95% confidence interval [CI], 1.24 to 2.09 in men; and RR, 1.80; 95% CI, 1.43 to 2.28 in women). In women, the excess risk was already pronounced 5 years prior to the year of diagnosis, whereas in men the highest risk was noticed 1 year before the year of diagnosis. CONCLUSION:Sleep apnea may severely threaten work ability years before diagnosis. These results emphasize the importance of the early identification and treatment of employees with sleep apnea.
Authors: Kirk Kee; John Dixon; Jonathan Shaw; Elena Vulikh; Markus Schlaich; David M Kaye; Paul Zimmet; Matthew T Naughton Journal: J Clin Sleep Med Date: 2018-12-15 Impact factor: 4.062
Authors: Anne Kouvonen; Mika Kivimäki; Tuula Oksanen; Jaana Pentti; Tarja Heponiemi; Ari Väänänen; Marianna Virtanen; Jussi Vahtera Journal: Am J Public Health Date: 2012-05-17 Impact factor: 9.308
Authors: Mayris P Webber; Roy Lee; Jackie Soo; Jackson Gustave; Charles B Hall; Kerry Kelly; David Prezant Journal: Sleep Breath Date: 2010-07-01 Impact factor: 2.816
Authors: Tea Lallukka; Risto Kaikkonen; Tommi Härkänen; Erkki Kronholm; Timo Partonen; Ossi Rahkonen; Seppo Koskinen Journal: Sleep Date: 2014-09-01 Impact factor: 5.849
Authors: Euny C Lee; Ellen P Simon; Jillian Nickerson; Barbara Brenner; Sandra Talavera; Crispin Goytia; Guedy Arniella; Carol R Horowitz Journal: Int Public Health J Date: 2013
Authors: Mika Kivimäki; Adam G Tabák; Debbie A Lawlor; G David Batty; Archana Singh-Manoux; Markus Jokela; Marianna Virtanen; Paula Salo; Tuula Oksanen; Jaana Pentti; Daniel R Witte; Jussi Vahtera Journal: Diabetes Care Date: 2010-04-05 Impact factor: 17.152